161 related articles for article (PubMed ID: 2415472)
21. The mast cell-committed progenitor. I. Description of a cell capable of IL-3-independent proliferation and differentiation without contact with fibroblasts.
Jarboe DL; Marshall JS; Randolph TR; Kukolja A; Huff TF
J Immunol; 1989 Apr; 142(7):2405-17. PubMed ID: 2784462
[TBL] [Abstract][Full Text] [Related]
22. Mast cells and tumour angiogenesis: new insight from experimental carcinogenesis.
Crivellato E; Nico B; Ribatti D
Cancer Lett; 2008 Sep; 269(1):1-6. PubMed ID: 18450371
[TBL] [Abstract][Full Text] [Related]
23. The neuronal cell-surface molecule mitogenic for Schwann cells is a heparin-binding protein.
Ratner N; Hong DM; Lieberman MA; Bunge RP; Glaser L
Proc Natl Acad Sci U S A; 1988 Sep; 85(18):6992-6. PubMed ID: 3413130
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the effect of mast cell granules on lymphocyte blastogenesis in the absence and presence of mitogens: identification of heparin as a granule-associated suppressor factor.
Frieri M; Metcalfe DD
J Immunol; 1983 Oct; 131(4):1942-8. PubMed ID: 6413584
[TBL] [Abstract][Full Text] [Related]
25. Biochemical and microscopic evidence for the internalization and degradation of heparin-containing mast cell granules by bovine endothelial cells.
Atkins FM; Friedman MM; Metcalfe DD
Lab Invest; 1985 Mar; 52(3):278-86. PubMed ID: 3974200
[TBL] [Abstract][Full Text] [Related]
26. Toward an understanding of angiogenesis: search and discovery.
Folkman J
Perspect Biol Med; 1985; 29(1):10-36. PubMed ID: 2415913
[No Abstract] [Full Text] [Related]
27. Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis.
Matsuzaki K; Yoshitake Y; Matuo Y; Sasaki H; Nishikawa K
Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9911-5. PubMed ID: 2481318
[TBL] [Abstract][Full Text] [Related]
28. Mast cell chymase in complex with heparin proteoglycan is regulated by protamine.
Pejler G
FEBS Lett; 1996 Apr; 383(3):170-4. PubMed ID: 8925890
[TBL] [Abstract][Full Text] [Related]
29. [The non-anticoagulant action of heparins: prospects].
Tobelem G
Rev Prat; 1988 May; 38(15):957-60. PubMed ID: 2455930
[No Abstract] [Full Text] [Related]
30. Localization of carboxypeptidase A to the macromolecular heparin proteoglycan-protein complex in secretory granules of rat serosal mast cells.
Schwartz LB; Riedel C; Schratz JJ; Austen KF
J Immunol; 1982 Mar; 128(3):1128-33. PubMed ID: 6799569
[No Abstract] [Full Text] [Related]
31. The basic residues of placenta growth factor type 2 retrieve sequestered angiogenic factors into a soluble form: implications for tumor angiogenesis.
Barillari G; Albonici L; Franzese O; Modesti A; Liberati F; Barillari P; Ensoli B; Manzari V; Santeusanio G
Am J Pathol; 1998 May; 152(5):1161-6. PubMed ID: 9588884
[TBL] [Abstract][Full Text] [Related]
32. Endothelial cell-stimulating angiogenesis factor in vitreous from extraretinal neovascularizations.
Taylor CM; Kissun RD; Schor AM; McLeod D; Garner A; Weiss JB
Invest Ophthalmol Vis Sci; 1989 Oct; 30(10):2174-8. PubMed ID: 2477343
[TBL] [Abstract][Full Text] [Related]
33. The molecular basis for the storage and release of histamine in rat mast cell granules.
Uvnäs B
Life Sci; 1974 Jun; 14(12):2355-66. PubMed ID: 4143643
[No Abstract] [Full Text] [Related]
34. Mast Cell Proteases 6 and 7 Stimulate Angiogenesis by Inducing Endothelial Cells to Release Angiogenic Factors.
de Souza Junior DA; Borges AC; Santana AC; Oliver C; Jamur MC
PLoS One; 2015; 10(12):e0144081. PubMed ID: 26633538
[TBL] [Abstract][Full Text] [Related]
35. Mast cell contribution to angiogenesis related to tumour progression.
Ribatti D; Crivellato E; Roccaro AM; Ria R; Vacca A
Clin Exp Allergy; 2004 Nov; 34(11):1660-4. PubMed ID: 15544587
[TBL] [Abstract][Full Text] [Related]
36. Mast cells and tumors. The specific enhancement of tumor proliferation in vitro.
Roche WR
Am J Pathol; 1985 Apr; 119(1):57-64. PubMed ID: 3985123
[TBL] [Abstract][Full Text] [Related]
37. Heparanase-mediated cleavage of macromolecular heparin accelerates release of granular components of mast cells from extracellular matrices.
Higashi N; Waki M; Sue M; Kogane Y; Shida H; Tsunekawa N; Hasan A; Sato T; Kitahara A; Kasaoka T; Hayakawa Y; Nakajima M; Irimura T
Biochem J; 2014 Mar; 458(2):291-9. PubMed ID: 24344642
[TBL] [Abstract][Full Text] [Related]
38. Signal transduction pathways in mast cell granule-mediated endothelial cell activation.
Chi L; Stehno-Bittel L; Smirnova I; Stechschulte DJ; Dileepan KN
Mediators Inflamm; 2003 Apr; 12(2):79-87. PubMed ID: 12775357
[TBL] [Abstract][Full Text] [Related]
39. [Angiogenic factors].
Camez A; Tobelem G
Nouv Rev Fr Hematol (1978); 1987; 29(1):57-9. PubMed ID: 2438646
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of the growth of IL-3-dependent mast cells from murine bone marrow by recombinant granulocyte macrophage-colony-stimulating factor.
Bressler RB; Thompson HL; Keffer JM; Metcalfe DD
J Immunol; 1989 Jul; 143(1):135-9. PubMed ID: 2471732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
